| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |